Yale Fibrosis Symposium

Nov 13th, 2013Nov 14th, 2013
Orange, CT
US
http://tiny.cc/yfs7
Phone:203-785-4578
This symposium endeavors to leverage cross-disciplinary expertise in the basic sciences, clinical medicine, and industry, with the ultimate goal of translating promising research into successful fibrosis treatments.
Latest in Home
Radiologist Computer Screen X Ray
Imaging turnaround times continued to climb in 2024
August 4, 2026
(A) Free-response receiver operating characteristic (FROC) curve for DBT-DINO and DINOv2 (Meta AI) on the detection task. DINOv2 achieved higher sensitivity than DBT-DINO across most false-positive thresholds. (B) Detection rates of DBT-DINO and DINOv2 for lesions that were ultimately found to be benign (n = 70) and lesions that were found to be cancerous (n = 66). Error bars represent 95% CIs estimated via patient-level bootstrapping with 1000 repetitions. Both models showed similar detection rates for cancerous lesions, whereas DINOv2 detected more benign lesions than DBT-DINO. (C) Example bounding box predictions for DBT-DINO and DINOv2 on the detection test set. Each image is a single two-dimensional section from a three-dimensional digital breast tomosynthesis volume; the first column shows a mediolateral oblique view, and the second and third columns show craniocaudal views. Both models struggled to detect very small lesions, such as the 3-mm-diameter lesion shown in the first column. FP = false positive.
DBT-based foundational model classifies breast density
August 4, 2026
Ct Contrast
Liebel-Flarsheim recalls Optiray CT contrast agent
August 4, 2026
Ai Head
Can LLMs fill the communication gap with referring clinicians?
August 4, 2026
More in Home
Imaging turnaround times continued to climb in 2024
By Erik L. Ridley
The largest increases were found in ultrasound and x-ray.
August 4, 2026
Radiologist Computer Screen X Ray
DBT-based foundational model classifies breast density
By Amerigo Allegretto
DBT-DINO showed strong performance in classifying breast density from DBT images.
August 4, 2026
(A) Free-response receiver operating characteristic (FROC) curve for DBT-DINO and DINOv2 (Meta AI) on the detection task. DINOv2 achieved higher sensitivity than DBT-DINO across most false-positive thresholds. (B) Detection rates of DBT-DINO and DINOv2 for lesions that were ultimately found to be benign (n = 70) and lesions that were found to be cancerous (n = 66). Error bars represent 95% CIs estimated via patient-level bootstrapping with 1000 repetitions. Both models showed similar detection rates for cancerous lesions, whereas DINOv2 detected more benign lesions than DBT-DINO. (C) Example bounding box predictions for DBT-DINO and DINOv2 on the detection test set. Each image is a single two-dimensional section from a three-dimensional digital breast tomosynthesis volume; the first column shows a mediolateral oblique view, and the second and third columns show craniocaudal views. Both models struggled to detect very small lesions, such as the 3-mm-diameter lesion shown in the first column. FP = false positive.
Liebel-Flarsheim recalls Optiray CT contrast agent
By AuntMinnie.com staff writers
The CT contrast agent may contain particulate matter comprising polyethylene, other plastic materials, stainless steel, and glass.
August 4, 2026
Ct Contrast
Can LLMs fill the communication gap with referring clinicians?
By Will Morton
LLMs could potentially help address multiple persistent pain points in radiology workflow.
August 4, 2026
Ai Head
CT-selected thrombectomy shows 1-year benefit in large-core stroke
By Will Morton
Notably, the TESLA trial used a noncontrast CT (NCCT)-alone patient selection protocol.
August 3, 2026
Aneurysm
MRI-based AI model maps local brain aging
By Amerigo Allegretto
The model showed differences in brain structures for normal cognition, mild cognitive impairment, and Alzheimer’s disease.
August 3, 2026
Mri Scan Brain
Curium to acquire Lantheus in $8 billion deal
By AuntMinnie.com staff writers
The combined company would serve oncology, neurology, and cardiology patients across more than 70 countries.
August 3, 2026
Cash Bills
Surveillance imaging doesn't improve pancreatic cancer survival
By Amerigo Allegretto
Study authors are calling for better strategies for early detection and intervention for pancreatic cysts that become malignant.
August 3, 2026
A.) Rate of imaging utilization during surveillance by year, 2008 to 2022. B.) Rate of endoscopic ultrasound (EUS) and pancreatic surgery per 100 person years, 2008 to 2022.
ED patients prefer empathetic communication for incidental findings
By Amerigo Allegretto
Incorporating patient preferences into communication may improve understanding and follow-up in addressing incidental findings.
July 31, 2026
Emergency 400
PET/MRI detects arterial inflammation in prostate cancer patients
By Will Morton
Androgen deprivation therapy (ADT) is widely used in advanced prostate cancer, yet is associated with increased cardiovascular events such as stroke and heart attacks.
July 31, 2026
Representative axial fused F-18 FDG-PET/MRI images and corresponding anatomic MRI images from a patient imaged at baseline and after initiation of androgen deprivation therapy are shown. Each row displays a distinct vascular territory. White arrows indicate focal areas of increased tracer uptake within the arterial wall, where spherical volumes of interest (VOIs) were placed for maximum standardized uptake value (SUVmax) measurement. Additional VOIs were placed in the superior vena cava and inferior vena cava for blood-pool activity sampling. SUVmax values from the arterial VOIs were extracted on the corresponding PET images and normalized to the blood-pool mean standardized uptake value to derive the maximum target-to-background ratio.
Women's Imaging MinnieCast, Episode 14: GLP-1s and breast cancer risk
By Amerigo Allegretto
Elizabeth McDonald, MD, shares results from her team's study on how GLP-1s may have beneficial effects on breast cancer risk.
July 31, 2026
Minnie Cast Thumbnail (17)
Podcast: The PACSMan Pontificates, Episode 4: The perfect PACS
By Michael J. Cannavo
In episode 4 of his The PACSMan Pontificates podcast series, Michael J. Cannavo shares his thoughts on the quest for the perfect PACS.
July 30, 2026
Pacs Man Pontification
Page 1 of 242
Next Page